Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Clinical trial NCT06807437 · RECRUITING

Trial details

NCT number: NCT06807437
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Carcinoma Pancreatic Neoplasm

Start date: 2025-05-09
Primary completion: 2027-11-01
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.